A phase I safety study of NPC-1C: A novel, therapeutic antibody to treat pancreas and colorectal cancers.
Philip M. Arlen
Employment or Leadership Position - Neogenix Oncology
Stock Ownership - Neogenix Oncology
Luis A. Diaz
No relevant relationships to disclose
Nilofer Saba Azad
No relevant relationships to disclose
Leanne Sophia Sleer
Employment or Leadership Position - Neogenix Oncology
Sherri Haley
No relevant relationships to disclose
Michael Morse
No relevant relationships to disclose